The SNY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SNY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The SNY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View SNY Detailed Price Forecast - CNN Money||View SNY Detailed Summary - Google Finance|
|View SNY Detailed Summary - Yahoo! Finance||View SNY Stock Research & Analysis - Zacks.com|
|View SNY Trends & Analysis - Trade-Ideas||View SNY Major Holders - Barrons|
|View SNY Call Transcripts - NASDAQ||View SNY Breaking News & Analysis - Seeking Alpha|
|View SNY Annual Report - CompanySpotlight.com||View SNY OTC Short Report - OTCShortReport.com|
|View SNY Fundamentals - TradeKing||View SNY SEC Filings - Bar Chart|
|View Historical Prices for SNY - The WSJ||View Performance/Total Return for SNY - Morningstar|
|View the Analyst Estimates for SNY - MarketWatch||View the Earnings History for SNY - CNBC|
|View the SNY Earnings - StockMarketWatch||View SNY Buy or Sell Recommendations - MacroAxis|
|View the SNY Bullish Patterns - American Bulls||View SNY Short Pain Metrics - ShortPainBot.com|
|View SNY Stock Mentions - StockTwits||View SNY Stock Mentions - PennyStockTweets|
|View SNY Stock Mentions - Twitter||View SNY Investment Forum News - Investor Hub|
|View SNY Stock Mentions - Yahoo! Message Board||View SNY Stock Mentions - Seeking Alpha|
|View Insider Transactions for SNY - SECform4.com||View Insider Transactions for SNY - Insider Cow|
|View SNY Major Holdings Summary - CNBC||View Insider Disclosure for SNY - OTC Markets|
|View Insider Transactions for SNY - Yahoo! Finance||View Institutional Holdings for SNY - NASDAQ|
|View SNY Stock Insight & Charts - FinViz.com||View SNY Investment Charts - StockCharts.com|
|View SNY Stock Overview & Charts - BarChart||View SNY User Generated Charts - Trading View|
Mylan says Sanofi loses Lantus insulin patent claims
Posted on Thursday December 13, 2018
Sanofi is heavily reliant on Lantus, its leading product with sales of 4.62 billion euros ($5.26 billion) in 2017, and Mylan's own insulin drug would be its second competitor after Eli Lilly launched its version in late 2016. Lantus is a long-acting insulin used to treat adults with type 2 diabetes and adults and paediatric patients with type 1 diabetes to control high blood sugar. Sanofi, which settled a similar case with Lilly in 2016, allowing it to launch Basaglar, sued Mylan in October 2017.
Mylan says patent office cancels Sanofi's Lantus patents
Posted on Thursday December 13, 2018
Mylan N.V. said on Thursday the U.S. Patent and Trademark Office invalidated French drug company Sanofi's formulation patents on its blockbuster insulin drug Lantus, ruling in favor of the U.S. drugmaker. ...
Warren Buffett's 10 Big Stock Losers
Posted on Tuesday December 11, 2018
Boehringer Ingelheim plans to cut about 300 jobs in France
Posted on Monday December 10, 2018
German drugmaker Boehringer Ingelheim told unions on Monday that it plans to cut some 300 jobs in France as part of efforts to reorganise activities around its hub in Lyon following an asset swap with Sanofi (SASY.PA) in 2017. Unlisted Boehringer agreed in January last year to trade its consumer health division in exchange for France's Sanofi animal health arm Merial in a $20 billion transaction. Boehringer Ingelheim's chairman for France, Jean Scheftsik de Szolnok, told Reuters the company was planning to cut up to 327 jobs out of a 2,800 workforce in France.